India¡¯s Virchow Group To Make 200 Million Doses Per Year Of Russia¡¯s Sputnik V Vaccine
Russia's RDIF sovereign wealth fund said an agreement has been reached with India's Virchow Biotech to produce up to 200 million doses a year of the Sputnik V vaccine, as per a Reuters report.
Russia's RDIF sovereign wealth fund said an agreement has been reached with India's Virchow Biotech to produce up to 200 million doses a year of the Sputnik V vaccine, as per a Reuters report.
RDIF said full-scale commercial production would begin once the transfer of technology in the second quarter was completed.
NDTV
The announcement follows similar deals with Indian pharmaceutical firms Gland Pharma, Stelis Biopharma and Hetero.
"Virchow's proven capabilities in large-scale drug substance manufacturing should help meet the global demand for this vaccine," Dr. Tummuru Murali, Managing Director of Virchow Biotech, said in a statement issued by RDIF.
Arab News
India, the world's largest vaccine maker, has become one of the biggest producers of the Sputnik V shot outside Russia. Other countries producing it include Brazil, China and South Korea.
Dr. Reddy's Laboratories Ltd, which has run small clinical studies of Sputnik V in India, sought emergency-use approval for the vaccine last month, but India's drug regulator asked for more data from the Sputnik V developers.
